http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104530260-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a94679b7b8fda698c16888619a00cc9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
filingDate 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61ae3c7c156bee3a369f56aeba728e90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14e04af6a9add69dd007a50c8edc3629
publicationDate 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104530260-A
titleOfInvention Method for co-producing high-purity heparin sodium and dermatan sulfate from pig lungs
abstract The invention provides a method for co-producing high-purity heparin sodium and dermatan sulfate from pig lungs. According to the method, the pig lungs are adopted as a raw material for producing high-purity heparin sodium and high-purity dermatan sulfate through enzymolysis, ion exchange, classified elution, concentration and ethanol precipitation. Specifically, the method comprises the steps of obtaining two steps of eluate through substep elution with ion exchange, removing salt and concentrating by using an ultrafiltration method, and further performing alcohol precipitation, thereby obtaining the heparin sodium and dermatan sulfate. In elution of ion exchange resin, a gradient sodium chloride solution is adopted for elution, so that heparin sodium and dermatan sulfate can be separated in eluate of different concentrations, the separation of heparin sodium from dermatan sulfate is achieved, the purity of heparin sodium and dermatan sulfate is respectively improved, the titer of heparin sodium and dermatan sulfate is also improved, and the purity, the titer and the optical rotation of heparin sodium and dermatan sulfate all meet the requirements of a pharmacopeia. The method is simple in process, low in cost and high in yield, and the economic benefits of product can be greatly increased.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111040047-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110172107-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107936139-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110172107-A
priorityDate 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32756
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414884733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683

Total number of triples: 33.